Antiviral efficacy of RAY1216 monotherapy and combination therapy with ritonavir in patients with COVID-19: a phase 2, single centre, randomised, double-blind, placebo-controlled trial
Wang et al., eClinicalMedicine, doi:10.1016/j.eclinm.2023.102189
https://c19early.org/wang29.html